7th Circ. Declines To Revive Humira 'Patent Thicket' Claims

By Hailey Konnath and Bryan Koenig · August 1, 2022, 8:08 PM EDT

A Seventh Circuit panel on Monday refused to revive landmark private antitrust claims from Humira buyers accusing pharmaceutical giant AbbVie of using a "patent thicket" to illegally shield the blockbuster immunosuppressant...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Mayor and City Council of Baltimore, et al v. AbbVie Inc., et al

Case Number

20-2402

Court

Appellate - 7th Circuit

Nature of Suit

3410 Antitrust

Date Filed

July 30, 2020